More interestingly, Cazzato et al found that TIM-3 was accompanied by the expression of another ligand, high mobility group box 1(HMGB-1), in CD4+ and CD8+ T cells from skin biopsy samples of COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.